StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Regeneron Pharma (REGN) PT Raised to $553 at Morgan Stanley
January 19, 2021 2:35 AM
Morgan Stanley analyst Matthew Harrison ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst PT Change